Palisade Bio Inc. (PALI) Social Stream
PALISADE BIO INC (PALI) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering PALI.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-09-02 | 1 | $7 | $7 | $7 | $0.543 | 1189.13% |
| 2022-03-25 | 2 | $7 | $5 | $6 | $0.543 | 1004.97% |
| 2022-05-17 | 2 | $5 | $3 | $4 | $0.543 | 636.65% |
| 2022-08-23 | 2 | $1.5 | $1.5 | $1.5 | $0.543 | 176.24% |
| 2023-03-26 | 2 | $25 | $25 | $25 | $0.543 | 4504.05% |
| 2023-03-30 | 2 | $50 | $25 | $37.5 | $0.543 | 6806.08% |
| 2023-05-17 | 2 | $16 | $16 | $16 | $0.543 | 2846.59% |
| 2023-10-27 | 2 | $3 | $3 | $3 | $0.543 | 452.49% |
| 2023-12-08 | 2 | $3 | $1.5 | $2.25 | $0.543 | 314.36% |
The Trend in the Analyst Price Target
PALI's average price target has moved down $22.75 over the prior 44 weeks.
PALI reports an average of 851.94% for its upside potential over the past 44 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-01 | 2 | 25 | 25.0 | 25.00 | 2.71 | 822.51% |
| 2023-03-30 | 2 | 50 | 25.0 | 37.50 | 2.65 | 1315.09% |
| 2023-05-17 | 2 | 16 | 16.0 | 16.00 | 1.61 | 893.79% |
| 2023-05-17 | 2 | 50 | 16.0 | 33.00 | 1.61 | 1949.69% |
| 2023-11-20 | 2 | 3 | 1.5 | 2.25 | 0.60 | 275% |
PALI Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 2 | 0 | 0 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
PALI's average broker recommendation rating improved by 1 over the prior 13 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, PALISADE BIO INC's number of analysts covering the stock is higher than 31.13% of them.
- PALISADE BIO INC's upside potential (average analyst target price relative to current price) is greater than 1157.26% of all US stocks.
- To contextualize these metrics, consider that out of stocks in the small market cap category, PALISADE BIO INC's variance in analysts' estimates is lower than -225.52% of them.
- PALISADE BIO INC's average analyst price target is greater than 425.38% of stocks in the small market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to PALISADE BIO INC are CRDF, CRIS, and AIM.
View All Top Stocks by Price Target
Make investment decisions regarding PALI using the data that counts. Try POWR Ratings for free.